CYGNOS BioTech LLC
Company

CYGNOS BioTech LLC

Biotechnology Research Miami, Fl, United States 4 employees
Employees
4
Contacts
2
Emails
2
Phones
2

CYGNOS BioTech LLC Overview

Headquarters
Miami, Fl, United States
Industry
Biotechnology Research
Employees
4
Founded
2022
Funding
,
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About CYGNOS BioTech LLC

CYGNOS BioTech is developing propriety antimicrobial therapeutics protected under several patents. PVX that will be commercialized for human and veterinary clinical markets. PVX is currently manufactured by chemical modification of the protein to ultimately promote biologic activity, either antiviral or antitumor (MMX). CYGNOS PVX has already demonstrated efficacy in companion animals (dogs, cats, horses and birds). CYGNOS has been awarded 2 FDA investigational product INADs for PVX and MMX. In parallel, CYGNOS is seeking funding to advance product development through FDA for the approval of the Animal INADs and a Human IND submission.

CYGNOS BioTech LLC Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

CYGNOS BioTech LLC Org Chart

Sample employees and titles
Name Title Contact
Jay Yourist Cygnos Biotech, Llc Founding Member
Email Phone
Walid Chaar CTO
Email Phone
John A. Bogdan, Jr President @ Valaria Technical
View
Debbie Somers Chief Operating Officer
View

Employees by Management Level

Executive 3 profiles
Individual contributor 1 profile

Compare Similar Companies to CYGNOS BioTech LLC